搜索
产品
社区
市场
新闻
经纪商
更多
CN
开始
Vertex intrinsic value estimation
做多
Vertex Pharmaceuticals Incorporated
(
NASDAQ:VRTX
)
viveredidividendi
NASDAQ:VRTX
Vertex Pharmaceuticals Incorporated
Fundamental Analysis
Value
Growth
6
0
fundamental
value
growth
Vertex at this time is a cash machine and seam undervalued according to DCF model. but everything depend on future treatment development so there is ah high value of volatility and risk related to this company.
免责声明
这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在
使用条款
阅读更多信息。